Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
FDA Approves Genzyme Corporation (GENZ)'s Gaucher Disease Pill Cerdelga 8/19/2014 4:24:02 PM
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Sclerosis Drug Plegridy 8/18/2014 6:10:52 AM
Merck & Co., Inc. (MRK) Wins FDA Approval For New Type Of Sleeping Pill 8/13/2014 2:32:55 PM
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014 7:22:41 AM
B.Braun Medical Receives FDA Approval For Nutrilipid® 20% 8/13/2014 8:15:19 AM
FDA Green Lights Johnson & Johnson (JNJ)'s Diabetes Drug Invokamet 8/11/2014 6:47:43 AM
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) Retreatment In Patients With Multiple Myeloma 8/11/2014 8:44:10 AM
FDA Approves The Medicines Company (MDCO)'s Acute Skin Infection Drug Orbactiv 8/6/2014 5:30:57 PM
European Commission (EC) Approves Roche (RHHBY)’s Avastin For Platinum-Resistant Recurrent Ovarian Cancer 8/6/2014 7:24:51 AM
Health Canada Approves Celgene Corporation (CELG)'s ABRAXANE® Plus Gemcitabine For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 8/6/2014 7:51:50 AM
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014 10:05:49 AM
FDA Approves Baxter International, Inc. (BAX)’s FLEXBUMIN 5%, First And Only 5% Human Albumin Solution In A Flexible Container 8/4/2014 11:02:20 AM
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients 7/31/2014 3:05:58 PM
FDA Green Lights Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes 8/1/2014 11:08:18 AM
Vertex Pharmaceuticals Incorporated (VRTX) Receives European Approval For KALYDECO™ (ivacaftor) In Eight Non-G551D Gating Mutations 8/1/2014 10:27:36 AM
1234567
//-->